Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Zainab M
Individuals with type 2 diabetes receiving GLP-1RA may discontinue treatment because of gastrointestinal side effects that can be associated with these drugs, a lack of efficacy, patient expectations or other reasons [8]
Tirzepatide - which acts on both GLP-1 and GIP receptors - is the active ingredient in Mounjaro (type 2 diabetes) and Zepbound (chronic weight management)
Enhanced Metabolic Health Weight loss medication are associated with significant improvements in key metabolic health indicators, such as optimized cholesterol profiles and better liver function metrics
C57BL/6J DIR-knockout mice were generated in-house at Helmholtz Munich (Supplementary Information 1)
US$ 29.66
US$ 23.92
US$ 24.12
US$ 20.49
US$ 25.56
